← Eichor
Condition: Hodgkin 39 S Lymphoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hodgkin 39 S Lymphoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use
NA · 1 location(s) · University of Washington · NCT06817122Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)
Phase 2/Phase 3 · 3 location(s) · Monash University · NCT07202091Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07059741Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies
Phase N/A · 1 location(s) · University Hospital, Angers · NCT07147621Evaluation of Skin Tests in Biotherapy Allergies
NA · 1 location(s) · University Hospital, Angers · NCT06971848Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
Phase 2/Phase 3 · 3 location(s) · Monash University · NCT07202078Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
Phase 2/Phase 3 · 3 location(s) · Monash University · NCT07202065
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.